SILEXION THERAPEUTICS CORP
Q1 2026 13F Holders
Symbol
SLXN
CUSIP
G1281K130
Type
Equity
Class
ORD SHS NEW
Num filers
7
Total reported value, excl. options
$46.7 k
Compare 2026 Q1 to
2025 Q4
2025 Q3
2025 Q2
Manager
Report Date
Value ($000)
Shares
Option Type